Skip to content

Alaris, SmartSite 2410-0500Recalls & reported problems

BD Switzerland Sàrl · Pump Infusion Set, 2 Y-Sites 290 cm (114 in) · Class 2

All models of Alaris, SmartSite (160)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
4
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 07613203012492), received between Oct 4, 2018 and Nov 23, 2021 — classified as 4 malfunctions.

The most frequently reported specific device problem is “Backflow” (2 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Sep 11, 2025Class IOpen, Classified

    Infusion pump module used with compatible pump infusion sets may perform outside the established performance ranges for flow rate and bolus accuracy, downstream and upstream occlusion time to alarm, and post-occlusion bolos volume.

    Z-0035-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Backflow2
  • Complete Blockage2
  • Fluid/Blood Leak1
  • Free or Unrestricted Flow1

Patient problems

  • No Consequences Or Impact To Patient3
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.

  • MalfunctionNov 23, 2021Backflow; Complete Blockage; Backflow; Complete Blockage

    IT WAS REPORTED THAT A BD ALARIS PUMP MODULE SMARTSITE INFUSION SET HAD FLOW ISSUES AND BLOOD BACKFLOW. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: " IT WAS REPORTED BY THE CUSTOMER THAT WHEN USING THE PRIMARY AND SECONDARY TUBING, THE SECONDARY FLUID BACK UP INTO THE PRIMARY CONTAINER. "

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 12865562 ↗
  • MalfunctionJan 28, 2021Complete Blockage; Free or Unrestricted Flow; Complete Blockage; Free or Unrestricted Flow

    IT WAS REPORTED THAT AS LVP 20D DEHP 2SS HAD A BACK FLOW ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: UNKNOWN BATCH NO: UNKNOWN IT WAS REPORTED THAT THERE WAS A BACK FLOW ISSUE WHERE SECONDARY MEDICATION WAS FOUND IN THE PRIMARY MEDICATION BAG.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 11243462 ↗
  • MalfunctionMay 29, 2019Backflow; Backflow

    IT WAS REPORTED THAT WHEN SECONDARY TUBING WAS ATTACHED, THE CONTENTS OF THE SECONDARY BAG IMMEDIATELY ENTERED THE PRIMARY BAG. THERE WAS NO PATIENT HARM REPORTED. THE USER OBSERVED THE ISSUE, IDENTIFIED AND ADDRESSED THE PROBLEM DIRECTLY.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8649470 ↗
  • MalfunctionOct 4, 2018Fluid/Blood Leak; Fluid/Blood Leak

    THE REPORT SUGGESTS THAT A LEAK WAS IDENTIFIED FROM THE OPENED AIRVENT DURING A CYCLOPHOSPHAMIDE INFUSION FROM A COLLAPSIBLE BAG. FROM THE REPORTED INFORMATION THERE ARE NO INDICATIONS OF SERIOUS INJURY TO THE PATIENT OR USER AS A RESULT OF THIS INCIDENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7934965 ↗

Other Set, administration, intravascular devices

All Set, administration, intravascular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page